Anaphylaxis
New Jersey caps out-of-pocket inhaler, epinephrine autoinjector costs
Gov. Phil Murphy of New Jersey has signed legislation that will cap monthly out-of-pocket prescription costs for epinephrine autoinjectors at $25 and asthma inhalers at $50 in all state-regulated and public employee health insurance plans.
Alpha-gal in health products triggers anaphylaxis in half of alpha-gal syndrome patients
Nearly half of patients with alpha-gal syndrome have had an anaphylactic reaction to health products that include alpha gal, according to a study presented at the DIA 2023 Annual Global Meeting in Boston.
FDA extends target action date for epinephrine nasal spray to September
The FDA has extended the prescription drug user fee act target action date for the new drug application for neffy intranasal epinephrine spray from ARS Pharmaceuticals to Sept. 19, according to a company press release.
FDA advisory committee votes in support of epinephrine nasal spray for anaphylaxis
The U.S. FDA Pulmonary-Allergy Drug Advisory Committee said available data support a favorable benefit-risk assessment for ARS Pharmaceuticals’ neffy nasal spray in treating anaphylaxis in adults and in children who weigh at least 30 kg.
High-grade reactions requiring epinephrine rare during at-home oral immunotherapy
Severe reactions during home oral immunotherapy were rare, and milk OIT, asthma and sensitization to house dust mite were the main risk factors, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
California legislation requires accessible epinephrine in schools
When a child has an anaphylactic reaction in school, prompt administration of epinephrine can be lifesaving. Yet autoinjectors often are kept under lock and key in the nurse’s office, and school personnel lack the training to use them.
Highlights from the Pediatric Academic Societies Meeting
This week, Healio provided live coverage of the Pediatric Academic Societies Meeting, an annual collaboration between the AAP, Academic Pediatrics Association, American Pediatric Society and the Society for Pediatric Research.
VIDEO: Observation time for anaphylaxis can safely be reduced
WASHINGTON — Study findings suggest that most children who visit the ED with anaphylaxis can safely be discharged after 2 hours of observation or less, researchers reported at the Pediatric Academic Societies Meeting.
Educational tool increases knowledge, comfort among families with food allergy
After completing the FA Passport, caregivers felt more comfortable with leaving their food-allergic children with other caregivers, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Top news of March: Diphenhydramine, socioeconomics, alpha-gal syndrome, epinephrine, more
Our Food Allergy: Fact vs. Fiction column and research presented at the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting in San Antonio dominated our list of the most read stories in allergy and asthma for March.